| Name / ID | Type | Disease | RRID | Causal gene(s) | Mutation | Originating lab |
|---|---|---|---|---|---|---|
| Atn1Q112/+ mouse | Mouse Models | DRPLA | — |
ATN1 | 112Q | University of Washington |
| ? | Cell Lines | SCA1 | — |
ATXN1 | 29/60 CAG | University of Ferrara (UNIFE) |
| 04/009 | Cell Lines | SPG7 | — |
SPG7 | c.1529C>T (het) and p.Ala510V (exon 11) and c.1745G>A and p.Gly582Asp (exonl1) | University of Sydney |
| 08/081 | Cell Lines | SPG7 | — |
SPG7 | c.1529C>T (het) and p.A510V (exon 11) and c.1449+1G>A (het) (intron 10) | University of Sydney |
| 08/082 | Cell Lines | SPG7 | — |
SPG7 | c.1529C>T (het) and p.A510V (exon 11) and c.1449+1G>A (het) (intron 10) | University of Sydney |
| 1 | Cell Lines | SCA7 | — |
ATXN7 | 50 CAG | University of Califorania |
| 10 | Cell Lines | SCA3 | — |
ATXN3 | 71 CAG | University Medical Center Groningen (UMCG) |
| 11 | Cell Lines | SCA3 | — |
ATXN3 | 64 CAG | University Medical Center Groningen (UMCG) |
| 11-033 | Cell Lines | SCA1 | — |
ATXN1 | 32/43 CAG | University of Minnesota |
| 11-036 | Cell Lines | SCA1 | — |
ATXN1 | 30/41 CAG | University of Minnesota |
| 11-037 | Cell Lines | SCA1 | — |
ATXN1 | 33/46 CAG | University of Minnesota |
| 11/082 | Cell Lines | SPG7 | — |
SPG7 | c.1529C>T (het) and p.A510V (exon 11) and c.1727C>G (het) and p.S576W (exon 13) | University of Sydney |
| 121i-n6, -n10, -n12 | Cell Lines | SCA12 | — |
PPP2R2B | 12/65 CAG; parental line of 122i (isogenic line) | Johns Hopkins University |
| 122i | Cell Lines | SCA12 | — |
PPP2R2B | 12/10 CAG; CRISPR/Cas9n modified line from 121i-n6, -n10, -n12 (isogenic pair) | Johns Hopkins University |
| 13 | Cell Lines | SCA3 | — |
ATXN3 | 70 CAG | University Medical Center Groningen (UMCG) |
| 14/065 | Cell Lines | SPG7 | — |
SPG7 | c.1454_1462del (het) and p.Arg485_Glu487del (exon 11) and c.1529C>T (het) and p.A510V (exon 11) | University of Sydney |
| 15 | Cell Lines | SCA3 | — |
ATXN3 | 71 CAG | University Medical Center Groningen (UMCG) |
| 16 | Cell Lines | SCA3 | — |
ATXN3 | 71 CAG | University Medical Center Groningen (UMCG) |
| 17 | Cell Lines | SCA3 | — |
ATXN3 | 75 CAG | University Medical Center Groningen (UMCG) |
| 19 | Cell Lines | SCA3 | — |
ATXN3 | 61 CAG | University Medical Center Groningen (UMCG) |
| 2 | Cell Lines | SCA7 (unaffected family) | — |
ATXN7 | 10/10 CAG; father from 65 CAG SCA7) | University of Califorania |
| 20 | Cell Lines | SCA3 | — |
ATXN3 | 64 CAG | University Medical Center Groningen (UMCG) |
| 21 | Cell Lines | SCA3 | — |
ATXN3 | 74 CAG | University Medical Center Groningen (UMCG) |
| 22 | Cell Lines | SCA3 | — |
ATXN3 | 67 CAG | University Medical Center Groningen (UMCG) |
| 23 | Cell Lines | SCA3 | — |
ATXN3 | 65 CAG | University Medical Center Groningen (UMCG) |
| 24 | Cell Lines | SCA3 | — |
ATXN3 | 75 CAG | University Medical Center Groningen (UMCG) |
| 25 | Cell Lines | SCA3 | — |
ATXN3 | 80 CAG | University Medical Center Groningen (UMCG) |
| 27 | Cell Lines | SCA3 | — |
ATXN3 | 71 CAG | University Medical Center Groningen (UMCG) |
| 3 | Cell Lines | SCA7 | — |
ATXN7 | 65/10 CAG | University of Califorania |
| 380i | Cell Lines | SCA12 | — |
PPP2R2B | 9/10 CAG; CRISPR/Cas9n modified line from 380i-n9, -n11 (isogenic pair) | Johns Hopkins University |
| 380i-n9, -n11 | Cell Lines | SCA12 | — |
PPP2R2B | 9/69 CAG; parental line of 380i (isogenic line) | Johns Hopkins University |
| 4 | Cell Lines | SCA7 (unaffected family) | — |
ATXN7 | 10/10 CAG; mother from 70 CAG SCA7) | University of Califorania |
| 41Q | Cell Lines | SCA7 | — |
ATXN7 | 10/41 CAG | University of Capetown |
| 47Q | Cell Lines | SCA7 | — |
ATXN7 | 10/47 CAG | University of Capetown |
| 5 | Cell Lines | SCA7 | — |
ATXN7 | 30 CAG | University of Califorania |
| 5’UTR FMR1 (CGG)99 | Mouse Models | FXTAS | — |
FMR1 | Full human FMR1 5'UTR with 99 expanded CGG expressing both CGG RNA and FMRpolyG protein | Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) |
| 515i | Cell Lines | SCA12 | — |
PPP2R2B | 8/10 CAG; CRISPR/Cas9n modified line from 515i-n2, -n3, -n5 (isogenic pair) | Johns Hopkins University |
| 515i-n2, -n3, -n5 | Cell Lines | SCA12 | — |
PPP2R2B | 8/56 CAG; parental line of 515i (isogenic line) | Johns Hopkins University |
| 6 | Cell Lines | SCA7 | — |
ATXN7 | 70/10 CAG | University of Califorania |
| 7 | Cell Lines | SCA3 | — |
ATXN3 | 69 CAG | University Medical Center Groningen (UMCG) |
| 7078 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | c.2094-2A > G/Q4054* (compound heterozygous) | Obtained from: Radboud University Nijmegen Medical Center |
| 7168 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | K1715*/R4331Q (compound heterozygous) | Obtained from: Radboud University Nijmegen Medical Center |
| 7373 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | p.2801delQ (homozygous) | Obtained from: Radboud University Nijmegen Medical Center |
| 8 | Cell Lines | SCA3 | — |
ATXN3 | 72 CAG | University Medical Center Groningen (UMCG) |
| 9 | Cell Lines | SCA3 | — |
ATXN3 | 64 CAG | University Medical Center Groningen (UMCG) |
| A1015 | Cell Lines | AOA1 | — |
APTX | pW279X/pQ181X | Istituto Neurologico Carlo Besta |
| A53T α-syn transgenic mouse | Mouse Models | MSA/OPCA | — |
Sporadic | WT (M7, M12, M20) and mutant (M83, M91) A53T human α-syn, both hetero- and homozygous | University of Pennsylvania School of Medicine |
| AAR-242-003 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | Protein change: p.I513V (missense homozygous variant) | University of Bordeaux |
| AAR-334-009 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | Protein change: p.R961*(nonsense+missense heterozygous variant) | University of Bordeaux |
| AAR-437-014 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | Protein change: p.R272H (missense homozygous variant) | University of Bordeaux |
Twenty Twenty-Five
Designed with WordPress